scholarly article | Q13442814 |
P356 | DOI | 10.1111/BJD.12894 |
P698 | PubMed publication ID | 24593055 |
P50 | author | Chris Cardwell | Q37837978 |
Helen G Coleman | Q56754234 | ||
P2093 | author name string | L J Murray | |
C McCourt | |||
D G Powe | |||
M M Cantwell | |||
O Dolan | |||
P2860 | cites work | Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib | Q24594790 |
Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure | Q24799850 | ||
Dopamine agonists and the risk of cardiac-valve regurgitation | Q28281822 | ||
Final version of 2009 AJCC melanoma staging and classification | Q29614803 | ||
Adaptation and validation of the Charlson Index for Read/OXMIS coded databases | Q33522043 | ||
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom | Q33539292 | ||
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action | Q33574011 | ||
The sympathetic nervous system induces a metastatic switch in primary breast cancer | Q34134468 | ||
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment | Q35640172 | ||
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs | Q35875447 | ||
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 | ||
Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis development | Q36050681 | ||
β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study | Q36838466 | ||
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression | Q37120838 | ||
Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. | Q37412219 | ||
Current role of beta-blockers in the treatment of hypertension | Q37738897 | ||
Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. | Q37974217 | ||
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs | Q38336991 | ||
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor | Q39745162 | ||
Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion | Q39847402 | ||
Catecholamine effects on human melanoma cells evoked by alpha1-adrenoceptors. | Q40531125 | ||
β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study. | Q43962317 | ||
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes | Q45040932 | ||
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers | Q46870629 | ||
Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. | Q47772737 | ||
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. | Q52548040 | ||
Measuring cancer survival in populations: relative survival vs cancer-specific survival | Q53064419 | ||
Revised U.K. guidelines for the management of cutaneous melanoma 2010 | Q56828390 | ||
Expanding Our Therapeutic Options: Beta Blockers for Breast Cancer? | Q59232379 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diagnosis | Q16644043 |
P304 | page(s) | 930-938 | |
P577 | publication date | 2014-04-01 | |
P1433 | published in | British Journal of Dermatology | Q4970191 |
P1476 | title | Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study | |
P478 | volume | 170 |